BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGS
3726
DELISTED
PlayAGS
AGS
| $4.37M | ﹤0.01% |
846,679
-1,245,435
| -60% | -$7.24M |
|
3727
Harvard Bioscience
HBIO
$28.5M
| $4.35M | ﹤0.01% |
120,912
-184,888
| -60% | -$8.34M |
|
3728
Wave Life Sciences
WVE
$1.15B
| $4.34M | ﹤0.01% |
1,335,487
-1,602,299
| -55% | -$3.08M |
|
3729
Urban One Class D
UONEK
$23.1M
| $4.32M | ﹤0.01% |
100,956
+39,883
| +65% | +$2.32M |
|
|
BBLN
3730
DELISTED
Babylon Holdings Limited
BBLN
| $4.32M | ﹤0.01% |
+176,689
| New | +$7.71M |
|
|
BRDS
3731
DELISTED
Bird Global, Inc.
BRDS
| $4.3M | ﹤0.01% |
394,349
+305,336
| +343% | +$9.3M |
|
3732
Xos
XOS
$31.3M
| $4.28M | ﹤0.01% |
77,441
+73,494
| +1,862% | +$5.87M |
|
|
TGAN
3733
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $4.22M | ﹤0.01% |
+1,107,875
| New | +$7.07M |
|
|
DLA
3734
DELISTED
Delta Apparel Inc.
DLA
| $4.21M | ﹤0.01% |
148,332
+855
| +0.6% | +$25.1K |
|
3735
Suzano
SUZ
$10.4B
| $4.19M | ﹤0.01% |
442,026
+44,871
| +11% | +$472K |
|
3736
iShares Core 10+ Year USD Bond ETF
ILTB
$595M
| $4.18M | ﹤0.01% |
75,218
+7,863
| +12% | +$453K |
|
3737
P3 Health Partners
PIII
$33.8M
| $4.18M | ﹤0.01% |
22,474
+19,516
| +660% | +$5.44M |
|
3738
iShares US Equity Factor ETF
LRGF
$3.67B
| $4.16M | ﹤0.01% |
109,855
+5,504
| +5% | +$226K |
|
3739
Stevanato
STVN
$5.39B
| $4.14M | ﹤0.01% |
262,040
-1,324
| -0.5% | -$21.9K |
|
3740
Viant Technology
DSP
$252M
| $4.14M | ﹤0.01% |
815,163
+27,423
| +3% | +$164K |
|
|
MMAT
3741
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $4.13M | ﹤0.01% |
40,120
-100,131
| -71% | -$14.9M |
|
3742
CAE Inc. Common Shares
CAE
$8.5B
| $4.13M | ﹤0.01% |
167,810
+16,013
| +11% | +$397K |
|
3743
Viking Therapeutics
VKTX
$3.86B
| $4.12M | ﹤0.01% |
1,427,221
-3,720,240
| -72% | -$9.21M |
|
|
BELFB
3744
Bel Fuse Inc Class B
BELFB
$4.18B
| $4.12M | ﹤0.01% |
264,650
-5,527
| -2% | -$90K |
|
3745
Freedom Holding
FRHC
$9.81B
| $4.08M | ﹤0.01% |
92,050
+1,874
| +2% | +$86.1K |
|
|
ATCX
3746
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $4.06M | ﹤0.01% |
772,012
+43,315
| +6% | +$410K |
|
|
PTR
3747
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $4.06M | ﹤0.01% |
86,991
-14,672
| -14% | -$740K |
|
|
ADTH
3748
DELISTED
AdTheorent Holding Co
ADTH
| $4.05M | ﹤0.01% |
1,311,146
+702,165
| +115% | +$5.27M |
|
3749
SLR Investment Corp
SLRC
$715M
| $4.04M | ﹤0.01% |
275,833
+39,002
| +16% | +$627K |
|
3750
Cooper-Standard Automotive
CPS
$546M
| $4.02M | ﹤0.01% |
805,849
-702,426
| -47% | -$4.1M |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.